GWM
BSX icon

Gibbs Wealth Management’s Boston Scientific BSX Stock Holding History

Gibbs Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$224K Sell
3,573
-5,776
-62% -$462K 0.03% 413
2025
Q4 		$913K Sell
9,349
-1,401
-13% -$137K 0.22% 107
2025
Q3 		$1.05M Buy
+10,750
New +$1.11M 0.24% 95

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gibbs Wealth Management's BSX Position: Q1 2026 in Review

Gibbs Wealth Management reduced its Boston Scientific (BSX) stake by 62% in Q1 2026, selling an estimated $462K and leaving 3,573 shares worth $224K. The position accounts for 0.03% of the portfolio, ranked #413.

Gibbs Wealth Management first reported a position in BSX in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.05M in Q3 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Gibbs Wealth Management held 3,573 shares of Boston Scientific worth $224K as of Q1 2026.
  • Gibbs Wealth Management sold 5,776 Boston Scientific shares in Q1 2026, an estimated $462K.
  • Boston Scientific made up 0.03% of Gibbs Wealth Management's portfolio in Q1 2026, its #413 holding.
  • Gibbs Wealth Management first reported a position in Boston Scientific in Q3 2025 and has held it in 3 quarters since.
  • Gibbs Wealth Management's Boston Scientific position peaked at $1.05M in Q3 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.